COMMUNIQUÉS West-GlobeNewswire

Disclosure of voting rights at AGM in Vistin Pharma ASA
23/05/2024
Oslo, Norway, 23 May 2024 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total [...]
Disclosure of voting rights for Chair of the Board
23/05/2024
Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors. Hans Peter Bøhn is chair of PCI Biotech’s board of [...]
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
23/05/2024
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital [...]
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
23/05/2024
GUANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
23/05/2024
Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX ® System Successfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May 23, 2024 (GLOBE NEWSWIRE) -- [...]
EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
23/05/2024
Press Release A 5-year manufacturing contract to support the FOCUS-27 project sales trajectory This contract highlights EUROAPI’s know-how and the reliability of its premium Contract Manufacturing Organization services [...]
EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros
23/05/2024
Communiqué de presse Un contrat de fabrication de 5 ans qui soutiendra la trajectoire de ventes du projet FOCUS-27 Ce contrat souligne le savoir-faire d’EUROAPI et la fiabilité des services premium de Contract [...]
Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease
23/05/2024
Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Additional kidney function analyses strongly support Vivoryon’s shift in strategic focus to [...]
Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders
23/05/2024
Allschwil, Switzerland – May 23, 2024 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the [...]
IBA Business Update – First Quarter 2024
23/05/2024
Louvain-la-Neuve, Belgium, 23 May 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the first quarter ending 31 March 2024. Group [...]
IBA déclaration intermédiaire - Premier trimestre 2024
23/05/2024
Louvain-la-Neuve, Belgique, le 23 mai 2024 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, publie aujourd'hui la revue de ses activités pour le premier [...]
Cytokinetics Announces Pricing of Public Offering of Common Stock
23/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock at a price [...]
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
23/05/2024
Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points Strengthens balance sheet with cash, cash equivalents and short-term [...]
Progyny, Inc. Announces Additional Share Repurchase Program
22/05/2024
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a [...]
Adagene to Present at Investor Conferences in June
22/05/2024
SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its [...]
Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
22/05/2024
SAN MATEO, Calif. and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by [...]
Codexis to Participate in Jefferies Global Healthcare Conference
22/05/2024
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held [...]
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/05/2024
CHASKA, Minn., May 22, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization, today announced that [...]
Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
22/05/2024
GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer [...]

Pages